Resveratrol enhances cell‐mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis
- 13 January 2009
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 48 (8), 713-723
- https://doi.org/10.1002/mc.20517
Abstract
Toll‐like receptors (TLRs) activate signals that are critically involved in innate immune responses and that contribute to the initiation of adaptive immune responses. Resveratrol (trans‐3,5,4‐trihydroxystilbene), a polyphenol found in red grapes and in several other plant sources, is an effective chemopreventive agent in cutaneous chemical carcinogenesis. In this study, we investigated whether TLR4 was required for the chemopreventive action of resveratrol in DMBA skin carcinogenesis. For this purpose, mice with normal and deficient TLR4 function were compared when pretreated with resveratrol and then subjected to a DMBA‐induced skin carcinogenesis protocol. There were fewer tumors/group (P < 0.001) in resveratrol treated TLR4 competent C3H/HeN mice than in TLR4 deficient C3H/HeJ mice. In addition, the size of tumors in C3H/HeN mice was reduced in vivo and their survival in vitro was inhibited by resveratrol to a significantly greater extent than in C3H/HeJ mice. Resveratrol inhibited angiogenesis to a much greater extent in the TLR4 competent mice than in TLR4 deficient mice. IFN‐γ and IL‐12 levels were also increased in TLR4 competent mice compared to TLR4 deficient mice, and TLR4 competent C3H/HeN mice exhibited a greater increase in the cell‐mediated immune response to DMBA. The results of this study indicate that TLR4 is an important mediator of resveratrol chemoprevention in DMBA skin tumorigenesis. Published 2009 Wiley‐Liss, Inc.Keywords
This publication has 56 references indexed in Scilit:
- Antagonistic Roles of CD4+ and CD8+ T-Cells in 7,12-Dimethylbenz(a)anthracene Cutaneous CarcinogenesisCancer Research, 2008
- Human Langerhans’ cells and dermal‐type dendritic cells generated from CD34 stem cells express different toll‐like receptors and secrete different cytokines in response to toll‐like receptor ligandsImmunology, 2008
- Protective Role of Toll-like Receptor 4 during the Initiation Stage of Cutaneous Chemical CarcinogenesisCancer Research, 2008
- Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal TumorsGastroenterology, 2007
- Resveratrol: A review of preclinical studies for human cancer preventionToxicology and Applied Pharmacology, 2007
- UV-induced immune suppression and photocarcinogenesis: Chemoprevention by dietary botanical agentsCancer Letters, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- The Role of Toll-like Receptors in the Pathogenesis and Treatment of Dermatological DiseaseJournal of Investigative Dermatology, 2005
- Botanical antioxidants for chemoprevention of photocarcinogenesisFrontiers in Bioscience-Landmark, 2002
- Occupational Skin Cancer: A ReviewJournal of Occupational and Environmental Medicine, 1975